Effect of nitrosyl iron complexes and their thio ligands on the activity of phosphodiesterase and sarcoplasmic reticulum Ca2+-ATPase

被引:0
作者
L. V. Tat’yanenko
O. V. Pokidova
N. S. Goryachev
N. A. Sanina
G. I. Kozub
T. A. Kondrat’eva
O. V. Dobrokhotova
I. Yu. Pikhteleva
A. I. Kotelnikov
机构
[1] Russian Academy of Sciences,Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry
[2] Lomonosov Moscow State University,Faculty of Fundamental Physical and Chemical Engineering
[3] Scientific and Educational Center “Medical Chemistry” of Moscow State Regional University,undefined
来源
Russian Chemical Bulletin | 2023年 / 72卷
关键词
nitrosyl iron complexes; cyclic guanosine monophosphate phosphodiesterase; sarcoplasmic reticulum Ca; -ATPase;
D O I
暂无
中图分类号
学科分类号
摘要
The effect of certain NO donors, viz., nitrosyl iron complexes (NICs) and their functional thio ligands, on the activity of hydrolytic enzymes was studied taking cyclic guanosine monophosphate phosphodiesterase (cGMP PDE) and sarcoplasmic reticulum (SR) Ca2+-ATPase as examples. It was shown that mononuclear dinitrosyl complexes with 4-nitrophenyl- and 5-nitropyridin-2-ylthiols as well as the binuclear tetranitrosyl complex with 3-hydroxyphenylthiol competitively inhibit the cGMP PDE action with the inhibition constants, Ki, equal to 2.3 · 10−6, 1.0 · 10−4, and 8.7 · 10−5 mol L−1, respectively, and non-competitively inhibit the function of SR Ca2+-ATPase with Ki = 7.4 · 10−5, 7.9 · 10−5 and 1.1 · 10−5 mol L−1, respectively. The thio ligands of the complexes have little effect on the enzyme activity or do not affect it at all. The results obtained make it possible to predict the antihypertensive, antiaggregatory, and vasodilatory activities of the compounds studied.
引用
收藏
页码:1673 / 1679
页数:6
相关论文
共 146 条
  • [1] Ignarro L J(2002)undefined J. Physiol. Pharmacol. 53 503-undefined
  • [2] Sanina N A(2015)undefined New J. Chem. 39 1022-undefined
  • [3] Aldoshin S M(2017)undefined J. Coord. Chem. 70 1713-undefined
  • [4] Shmatko NY(2011)undefined Dalton Trans. 40 8273-undefined
  • [5] Korchagin D V(2008)undefined Methods Enzymol. 436 445-undefined
  • [6] Shilov G V(2022)undefined J. Mol. Struct. 1266 133506-undefined
  • [7] Knyazkina E V(2019)undefined J. Mol. Struct. 1181 321-undefined
  • [8] Ovanesyan N S(2018)undefined Inorg. Chim. Acta 480 132-undefined
  • [9] Kulikov A V(2007)undefined Circ. Res. 100 309-undefined
  • [10] Shaban S Y(1971)undefined Annu. Rev. Physiol. 33 311-undefined